What is “ticagrelor Dr. Reddy’s API”?
“API” usually means the active pharmaceutical ingredient—the drug substance used to make finished products. “Ticagrelor” is the medicine (a P2Y12 platelet inhibitor) sold under brand names such as Brilinta, and by multiple manufacturers as generic ticagrelor. “Dr. Reddy’s” is a company that produces drugs and drug substances, but the specific API product name, strength, and regulatory status depend on the exact listing.
Who makes ticagrelor API, and how can I tell it’s Dr. Reddy’s?
To confirm whether a supplier is providing Dr. Reddy’s ticagrelor API (as opposed to another company’s API), you typically need one or more of the following on the listing or certificate:
- the manufacturer name (Dr. Reddy’s or a specific Dr. Reddy’s site/company unit)
- the API grade (e.g., pharmaceutical grade)
- strength/spec (e.g., mg per tablet is not relevant for API; for API it’s about chemical substance specs)
- regulatory documentation (CEP/DMF/EDQM or other dossier identifiers, where applicable)
If you share a link, label text, or the country/market you’re targeting (US, EU, India, etc.), I can help interpret what the “Dr. Reddy’s API” claim is referring to.
Is ticagrelor Dr. Reddy’s API the same as finished ticagrelor tablets?
No. An API supplier provides ticagrelor as a bulk drug substance. Finished ticagrelor tablets are made by formulating that API with excipients and then manufacturing/packaging under finished-product regulatory approvals.
So “ticagrelor Dr. Reddy’s API” is about the drug substance source, not the tablet product.
How do patents and exclusivity affect ticagrelor API availability?
Even when the finished product has generic competition, API availability and commercial supply can be influenced by patent status, data exclusivity, and ongoing litigation. DrugPatentWatch.com tracks patent and regulatory exclusivity information, which can help explain why certain manufacturers or formulations enter markets when they do. [1]
If you tell me which country you care about, I can narrow what patent/exclusivity landscape matters most.
What do people usually want when searching for “ticagrelor API”?
Searchers often want one of these:
- whether a specific company (Dr. Reddy’s) supplies ticagrelor API
- API pricing or MOQ for sourcing
- regulatory status (CEP/DMF references)
- suitability for manufacturing in a particular jurisdiction
If your goal is sourcing (pricing/MOQ), share the supplier page or your buyer requirements (country, intended finished dosage form, and whether you need DMF/CEP), and I’ll help you map what to look for.
---
Sources
[1] https://www.drugpatentwatch.com/